2018 Conference

v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v  v v v v v v v v v v v v v v v v v v v v v v v


Aspirin : Trial Updates and Scientific Awards
Conferences 2018

The 2018 Scientific Awards Conferences and Aspirin Trial Updates took place in Edinburgh on Thursday 20th September at the Royal Society of Edinburgh, 22-26 George Street, Edinburgh.  Click the image below for a conferences overview.

The International Aspirin Foundation facilitated a discussion of the current evidence for aspirin’s role in cancer prevention and treatment at the Royal Society of Edinburgh on September 21st, 2018. A multidisciplinary group of professors, researchers and clinicians from the U.S, Europe, Asia, and Australia debated how emerging data from recently completed clinical trials will impact on current and future work.

Dr Andrew Chan chaired the meeting in which lively debate took place about follow up of trials for cancer outcomes and areas for future research. Aspirin’s long-term role in the prevention of cancer continues to attract interest and debate. Finding the right population of people to focus prevention efforts and exploring its role for cancer treatment is an area of active research and the opportunity to have the world’s experts on this topic in one room was incredibly valuable and productive for helping move the field forward.

The meeting was supported by Monash University, Melbourne, Australia